TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›ACHC

ACHC

Acadia Healthcare Company, Inc.

Next earnings Aug 3, 2026 (after close) · consensus $0.39 EPS, $861M rev

Last earnings +2.5% on 2026-04-29

Hold
$31.91
▲ +15.24%
$31.91▲ +45.71%
over 1Y
L $11.68H $31.91
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+15.2%
1W+21.6%
1M+30.7%
3M+33.2%
YTD+123.3%
1Y+45.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C+
Valuation
Fair value
Filings
Flagged
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 20 analysts
Buy

A ~$1B goodwill write-down masks still-cash-generative operations trading at 0.8x sales — cheap, but levered and burning FCF to grow.

Revenue (FY2025) $3.31B · FY2025

Acadia's headline FY2025 numbers look catastrophic — a -$1.10B net loss and -$12.16 diluted EPS versus +$256M of net income in FY2024 — but the damage is overwhelmingly a non-cash goodwill impairment, not an operational collapse. The guarantor disclosure makes this explicit: goodwill fell from $2,144M to $1,163M year over year (≈$981M write-down), which approximates the entire swing into loss. Underneath it, revenue still grew 5.0% to $3.31B, operating margin held at 17.7% (operating income $586M), and operating cash flow was positive at $132M. So the business is not unprofitable on a cash basis; the auditors and management simply concluded that prior acquisitions are worth roughly a billion dollars less than carried — a forward warning about reimbursement, occupancy, or specific market economics that the filing excerpt does not fully explain.

The more durable concern is the balance sheet and cash burn. Capex of $572M dwarfs the $132M of operating cash flow, implying roughly ~$440M of negative free cash flow funded by debt: long-term debt rose 31.5% to $2.47B, the company drew $954M on its new Revolving Facility, issued $550M of 7.375% Senior Notes (a notably higher coupon than its legacy 5.0%/5.5% notes), and equity fell 36.6% to $1.95B, pushing liabilities/equity to 1.74x. Cash is thin at $133M. This is a company leveraging up to fund de novo facility expansion (the MD&A references multiple development projects backed by letters of credit) while reported returns are deeply negative (ROE -56.6%). Revenue growth is also decelerating — +13%, +12%, +7.5%, +5.0% over the last four years — and FY2023 already produced a small loss, so the impairment is not a one-off bolt from the blue.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 11:54 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$2.31B$2.61B$2.93B$3.15B$3.31B
Gross profit—————
Operating income—————
Net income$191M$273M-$21.7M$256M-$1.10B
Diluted EPS$2.10$2.98-$0.24$2.78-$12.16
Net margin8.2%10.5%-0.7%8.1%-33.3%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$5.30B
EV / EBITDA6.8
EV / Sales1.6
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-37.6%
FCF yield-15.0%

Quality & risk

ROIC (est.)10.4%
Free cash flow-$440M
Total debt$2.50B
Net cash-$2.37B
Altman Z-Score1.34 distress
Piotroski F-Score5/8

Capital returns

Buyback yield1.7%
Dividend yield (est.)—
Shareholder yield1.7%
Shares Δ YoY-0.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Other event2026-05-18

    Other-events (Item 8.01) disclosure; no quantified financial impact specified

  2. 8-K Shareholder vote2026-05-06

    Annual meeting voting results: director elections and say-on-pay reported

  3. 10-Q Quarterly report2026-04-30

    Q1 2026: revenue still growing post-impairment, no new charge flagged

  4. 8-K Earnings results2026-04-29

    Q1 2026 earnings release issued day before the 10-Q

  5. 8-K Officer / director change2026-04-23

    Leadership change (Item 5.02): executive/director departure or appointment

  6. DEF 14A Proxy statement2026-03-25

    2026 proxy for May 6 annual meeting; routine governance/comp items

  7. 8-K Officer / director change2026-03-12

    Another officer/director change disclosed (Item 5.02)

  8. 10-K Annual report2026-02-27

    FY25 net loss $1.10B on ~$980M goodwill writedown; debt up, equity -37%

  9. 8-K Earnings results2026-02-25

    FY2025 results released: $1.10B net loss driven by goodwill impairment

Recent filings

all on EDGAR ↗
4Period ending 2026-06-262026-06-26open ↗8-KPeriod ending 2026-05-182026-05-18open ↗SCHEDULE 13G/AFiling2026-05-15open ↗SCHEDULE 13G/AFiling2026-05-15open ↗S-8Filing2026-05-11open ↗3Period ending 2026-05-012026-05-11open ↗SCHEDULE 13G/AFiling2026-05-11open ↗4Period ending 2026-05-062026-05-08open ↗4Period ending 2026-05-062026-05-08open ↗4Period ending 2026-05-062026-05-08open ↗4Period ending 2026-05-062026-05-08open ↗4Period ending 2026-05-062026-05-08open ↗

Quality score

C+
ValueGrowthProfitHealthMom.
ValueA+
GrowthF
ProfitabilityD
Financial healthC
MomentumA+
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
11.6852-week31.91
Revenue
$3.31B
+5.0% YoY
Net margin
-33.3%
ROE
-56.6%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$3.31B+5.0%
Net income-$1.10B-531.4%
Operating income$586M-1.3%
Diluted EPS-$12.16-537.4%
Cash & equivalents$133M+74.6%
Total assets$5.53B-7.2%
Total liabilities$3.39B+22.4%
Stockholders' equity$1.95B-36.6%
Op.: 17.7%L/E: 1.74x

Frequently asked

Is Acadia Healthcare Company, Inc. (ACHC) a buy?
ACHC currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. A ~$1B goodwill write-down masks still-cash-generative operations trading at 0.8x sales — cheap, but levered and burning FCF to grow.
What is Acadia Healthcare Company, Inc.'s quality score?
ACHC scores 62.48333333333334/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001520697, latest 10-Q filed 2026-04-30) · EODHD · Proprietary analysis · as of 6/30/2026, 3:54:51 AM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-26
Farley Brian
EVP, CLAO and Secretary
Tax1.37K @ $26.24$35.9K
2026-05-06
Fucci Michael
Director
Award6.33K
2026-05-06
KELLY RALPH DAVID
Director
Award6.33K
2026-05-06
Gregg Vicky B
Director
Award6.33K
2026-05-06
Bernhard Jason
Director
Award6.33K
2026-05-06
Bernhard Jason
Director
Award5.12K
2026-05-06
GRIECO WILLIAM
Director
Award6.33K
2026-05-06
Cancelmi Daniel J
Director
Award6.33K
2026-05-06
Harris Patrice A
Director
Award6.33K

Earnings history

beat/miss · move
2026-04-29Beat +36.4% est▲ +2.47%8-K ↗
2026-02-25Beat +18.2% est▲ +21.37%8-K ↗
2026-01-13Beat +18.2% est▼ -5.14%8-K ↗
2025-11-05Beat +5.2% est▲ +0.10%8-K ↗
2025-08-05Beat +17.1% est▲ +1.82%8-K ↗
2025-05-12—▲ +8.39%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2022-12-29Susie LeeSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
Hospital Chains Stocks Q1 Earnings Review: Universal Health Services (NYSE:UHS) ShinesBullish
finance.yahoo.com· 2026-06-29
Zacks Industry Outlook Highlights Tenet Healthcare, Universal Health Services, Acadia Healthcare and Community Health SystemsBullish
finance.yahoo.com· 2026-06-29
Hospital Stocks Are Healing: 4 Names to Watch as Earnings ImproveBullish
finance.yahoo.com· 2026-06-26
Can Acadia's Turnaround Strategy Drive Long-Term Shareholder Value?Bullish
finance.yahoo.com· 2026-06-23
Hospital Chains Stocks Q1 Teardown: HCA Healthcare (NYSE:HCA) Vs The RestBullish
finance.yahoo.com· 2026-06-22
Is Acadia Healthcare Company, Inc. (ACHC) A Good Stock To Buy Now?Bullish
finance.yahoo.com· 2026-06-19

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score62 vs 67
Revenue growth5.0% vs 7.5%
Net margin-33.3% vs 10.0%
Return on equity-56.6% vs 12.0%
P/E— vs 26.2

News sentiment

EODHD · 21d
Bullish
+0.17
vs typical · 28 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.